150
Participants
Start Date
October 31, 2007
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
Gemox, Cetuximab
"GEMOX (Arms 1 and 2), every two weeks:~Day 1: gemcitabine 1000 mg/m² intravenous (IV) infusion over 100 minutes (10 mg/m²/min) Day 2: oxaliplatin 100 mg/m² IV infusion over 2 h~Cetuximab (ErbituxÒ) (Arm B only) every two weeks:~(chemotherapy will be started one hour after the end of the cetuximab infusion).~Day 1 or Day 2: 500 mg/m² IV infusion over 150 minutes"
Institut Gustave Roussy, Villejuif
Merck Serono International SA
INDUSTRY
Gustave Roussy, Cancer Campus, Grand Paris
OTHER